Literature DB >> 5153084

Clinical evaluation of 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide in malignant melanoma and other neoplasms: comparison of twice-weekly and daily administration schedules.

J A Gottlieb, A A Serpick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5153084     DOI: 10.1159/000224572

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


× No keyword cloud information.
  2 in total

Review 1.  Chemotherapy in malignant mesothelioma: a review.

Authors:  A Krarup-Hansen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 2.  WITHDRAWN: Systemic treatments for metastatic cutaneous melanoma.

Authors:  Tom Crosby; Reg Fish; Bernadette Coles; Malcolm Mason
Journal:  Cochrane Database Syst Rev       Date:  2018-02-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.